Vytrus Biotech, S.A. (FRA:V5P)
Germany · Delayed Price · Currency is EUR 7.15
+0.10 (1.42%)
At close: Nov 28, 2025
Vytrus Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 1.95 | 1.02 | 0.54 | 0.61 | 0.45 | 0.22 | Upgrade |
Depreciation & Amortization | 0.27 | 0.19 | 0.19 | 0.15 | 0.58 | 0.39 | Upgrade |
Other Amortization | 0.64 | 0.64 | 0.53 | 0.54 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.03 | Upgrade |
Other Operating Activities | 0.16 | -0.25 | -0.09 | 0.08 | -0.7 | -0.62 | Upgrade |
Change in Accounts Receivable | -0.71 | -0.08 | -0.11 | -0.22 | -0.06 | -0.06 | Upgrade |
Change in Inventory | 0.02 | 0.03 | -0.14 | -0.16 | -0.04 | -0.06 | Upgrade |
Change in Accounts Payable | 0.61 | 0.21 | -0.02 | 0.07 | 0.22 | 0.02 | Upgrade |
Change in Other Net Operating Assets | 0.02 | 0.09 | -0.01 | -0.05 | 0 | -0.05 | Upgrade |
Operating Cash Flow | 2.96 | 1.84 | 0.9 | 1.03 | 0.45 | -0.13 | Upgrade |
Operating Cash Flow Growth | 111.95% | 103.87% | -11.86% | 129.06% | - | - | Upgrade |
Capital Expenditures | -0.26 | -0.1 | -0.14 | -0.42 | -0.22 | -0.18 | Upgrade |
Cash Acquisitions | -0 | -0 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -1.22 | -1.1 | -1.02 | -0.87 | -0.05 | -0.05 | Upgrade |
Sale (Purchase) of Real Estate | - | - | - | 0 | - | - | Upgrade |
Investment in Securities | -0.02 | 0 | -0.02 | -0.03 | -0.03 | -0 | Upgrade |
Investing Cash Flow | -1.5 | -1.2 | -1.18 | -1.33 | -0.3 | -0.24 | Upgrade |
Long-Term Debt Issued | - | 0.2 | 1.65 | 0.38 | 0.27 | 0.86 | Upgrade |
Long-Term Debt Repaid | - | -0.61 | -0.68 | -0.35 | -0.27 | -0.19 | Upgrade |
Net Debt Issued (Repaid) | -0.55 | -0.41 | 0.96 | 0.03 | -0.01 | 0.67 | Upgrade |
Issuance of Common Stock | 0.23 | 1.29 | 0.12 | 0.17 | 0.25 | - | Upgrade |
Repurchase of Common Stock | -0.14 | -0.14 | -0.42 | -0.46 | -0.2 | -0.03 | Upgrade |
Other Financing Activities | 0.07 | 0.04 | - | - | - | - | Upgrade |
Financing Cash Flow | -0.39 | 0.78 | 0.66 | -0.26 | 0.05 | 0.64 | Upgrade |
Net Cash Flow | 1.07 | 1.42 | 0.38 | -0.56 | 0.19 | 0.27 | Upgrade |
Free Cash Flow | 2.7 | 1.74 | 0.76 | 0.61 | 0.23 | -0.32 | Upgrade |
Free Cash Flow Growth | 105.02% | 128.46% | 25.94% | 166.43% | - | - | Upgrade |
Free Cash Flow Margin | 33.40% | 28.62% | 16.22% | 13.51% | 6.47% | -14.15% | Upgrade |
Free Cash Flow Per Share | - | 0.23 | 0.11 | - | 0.03 | -0.05 | Upgrade |
Cash Interest Paid | 0.09 | 0.09 | 0.1 | 0.06 | 0.08 | 0.06 | Upgrade |
Levered Free Cash Flow | 0.73 | 0.47 | -1.04 | -0.37 | 0.57 | 0.32 | Upgrade |
Unlevered Free Cash Flow | 0.8 | 0.55 | -0.94 | -0.24 | 0.64 | 0.4 | Upgrade |
Change in Working Capital | -0.05 | 0.24 | -0.27 | -0.36 | 0.12 | -0.15 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.